U.S. markets closed
  • S&P 500

    3,678.43
    +92.81 (+2.59%)
     
  • Dow 30

    29,490.89
    +765.38 (+2.66%)
     
  • Nasdaq

    10,815.43
    +239.82 (+2.27%)
     
  • Russell 2000

    1,708.87
    +44.15 (+2.65%)
     
  • Crude Oil

    83.25
    +3.76 (+4.73%)
     
  • Gold

    1,707.80
    +35.80 (+2.14%)
     
  • Silver

    20.75
    +1.72 (+9.01%)
     
  • EUR/USD

    0.9828
    +0.0027 (+0.28%)
     
  • 10-Yr Bond

    3.6510
    -0.1530 (-4.02%)
     
  • GBP/USD

    1.1321
    +0.0155 (+1.39%)
     
  • USD/JPY

    144.5800
    -0.1490 (-0.10%)
     
  • BTC-USD

    19,559.32
    +302.26 (+1.57%)
     
  • CMC Crypto 200

    444.05
    +8.70 (+2.00%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call; Declares Common Dividend

·1 min read

IRVINE, Calif., February 01, 2022--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2021 fourth quarter earnings release on February 22, 2022 before the market opens.

A conference call with a simultaneous webcast to discuss the 2021 fourth quarter results will be held on the same day at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 3672788.

The webcast URL is https://edge.media-server.com/mmc/p/r5to66um. A digital replay of the call will be available on our website at www.sabrahealth.com.

Also, on February 1, 2022, Sabra’s board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on February 28, 2022 to common stockholders of record as of the close of business on February 11, 2022.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220201005150/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com